Investor & Shareholders
Quarterly Results
Financial Highlights - 3yrs
Reports Gallery
Code of Conduct
Corporate Governance
Shareholding Patterns
Home Investor Quarterly Results Under
UNAUDITED STANDALONE FINANCIAL RESULTS (PROVISIONAL) FOR THE QUARTER
ENDED DECEMBER 31, 2008.
(Rs. In Lacs)
PARTICULARS
Quarter Ended 31/12/2008
Quarter Ended 31/12/2007
Six Months
Ended 31/12/2008
Six Months
Ended 31/12/2007
Year Ended 30/06/2008(Audited)
Net Sales / Income from Operations 9,432.76 7,812.61 18,528.58 15,158.89 33,461.60
Total Income 9,432.76 7,812.61 18,528.58 15,158.89 33,461.60
Total Expenditure          
a) Increase/(Decrease) in Stock in Trade (637.10) (412.39) (1,351.70) (971.13) (3,147.92)
b) Consumption of Materials 8,169.28 6,846.73 16,742.54 13,416.60 31,972.28
c) Purchases of Trading Goods 688.13 - 688.13 - -
d) Employees Cost 145.89 125.11 284.31 240.57 374.27
e) Depreciation 130.01 82.49 286.38 163.08 359.96
f) Other Expenditure 220.44 132.52 383.50 258.57 355.45
Total 8,716.65 6,774.46 17,033.16 13,107.69 29,914.04
Profit from Operations before Exchange Rate Difference,          
Other Income, Interest & Exceptional Items ( 1 - 2 ) 716.11 1,038.15 1,495.42 2,051.20 3,547.56
Other Income 60.82 31.58 140.18 51.74 250.51
Profit from Operations before Interest & Exceptional          
Items ( 3 + 4 ) 776.93 1,069.73 1,635.60 2,102.94 3,798.07
Interest 326.47 167.35 586.34 327.67 658.70
Exception Items 270.55 - (33.37) - -
Profit Before Tax ( 3 - 6 - 7 ) 721.01 902.38 1,015.89 1,775.27 3,139.37
Tax Expenses 80.00 190.00 118.00 365.50 420.57
Net Profit before ordinary activities ( 8 - 9 ) 641.01 712.38 897.89 1,409.77 2,718.80
Extra Oridinary Items (Net of Tax) - - - - -
Net Profit after Taxes ( 10 - 11) 641.01 712.38 897.89 1,409.77 2,718.80
Paid Up Equity Share Capital ( Face Value Of Rs. 10/- each) 1,055.69 1,018.20 1,055.69 1,018.20 1,055.69
Reserves excluding Revaluation - - - - -
Reserves - - - - 8,862.88
Earning Per Shares          
i) before extra ordinary items 6.07 7.00 8.51 13.85 25.75
ii) after extra ordinary items 6.07 7.00 8.51 13.85 25.75
Aggregate of Public Shareholdings        
No. of Shares 4,144,325 3,769,325 4,144,325 3,769,325 4,144,325
Percentage of Shareholdings 39.26% 37.02% 39.26% 37.02% 39.26%
         
NOTES :-
1) The above results for the quarter ended December 31, 2008 have been reviewed by the Audit Committee and were taken on record by
the Board of Directors in its meeting held on January 31, 2009.
2) The "Limited Review" required under clause 41 of listing agreement has been done by statutory auditors of the Company.
3) The Company has provided for Foreign Exchange (Loss)/Gains under Exception Items due to exchange differences arising during the
period(s) on foreign currency contracts and borrowings including Foreign Currency Convertible Bonds.
4) Previous years figures have been regrouped and recast wherever necessary.
5) Information on investor complaints for the quarter ended December 31, 2008 (in nos.)
Opening Balance of Complaints Received during the Quarter Disposed Off during the Quarter Closing Balance
NIL 2 2 NIL
 
Place : Mumbai.
Date :31.01.2009

By Order Of The Board
For SharonBio Medicine Ltd.

Sd/-       

Savita Gowda

Managing Director

.

 
 
© 2006-2009 Sharon Bio-Medicine Ltd.Website By: ETrends India